Čájehuvvojit 1 - 20 oktiibuot 56 bohtosis ohcui "Neoplasms therapy."', ohcanáigi: 0,03s Aiddostahte ozu
  1. 1

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  2. 2
  3. 3

    Optimal treatment of chronic pain

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  4. 4

    Symptom control using technology pragmatically /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  5. 5

    Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  6. 6

    Gene profiling in breast cancer

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  7. 7

    Principles of cancer treatment surgery, radiotherapy, chemotherapy, immunotherapy /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  8. 8

    Pain and symptom control in palliative care new ways to think about old drugs /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  9. 9

    The patient with pain a palliative care approach /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  10. 10

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  11. 11

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  12. 12

    Cancer pain control an evidence-based approach /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  13. 13

    Phase I study design for non-cytotoxic agents

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  14. 14

    UGT1A1 polymorphisms and irinotecan toxicity in colorectal cancer patients

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  15. 15

    The rational use of opioid analgesics for cancer pain with a critique of the WHO 3-step ladder /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  16. 16

    Spinal analgesia for cancer pain

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  17. 17

    Optimal treatment of chronic pain

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  18. 18

    Optimal treatment of chronic pain

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  19. 19

    Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  20. 20

    Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video